TY - JOUR
AU - J. Brown
AU - K. Wing
AU - S. Evans
AU - C. Leyrat
AU - K. Mansfield
AU - L. Smeeth
AU - A. Wong
AU - D. Yorston
AU - N. Galwey
AU - I. Douglas
AD - Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, United Kingdom.
Research and Development, GSK Medicines Research Centre, GSK, Stevenage, United Kingdom.
AN - 38814618
BT - JAMA Ophthalmol
C2 - PMC11140578 World Health Organization Europe and CorEvitas outside the submitted work. Dr Mansfield reported receiving personal fees from Amgen outside the submitted work. Dr Douglas reported receiving grants from GlaxoSmithKline during the conduct of the study and owning GlaxoSmithKline shares outside the submitted work. No other disclosures were reported.
DO - 10.1001/jamaophthalmol.2024.1712
DP - NLM
ET - 2024/05/30
LA - eng
N1 - 2168-6173
Brown, Jeremy P
Wing, Kevin
Evans, Stephen J
Leyrat, Clémence
Mansfield, Kathryn E
Smeeth, Liam
Wong, Angel Y S
Yorston, David
Galwey, Nicholas W
Douglas, Ian J
Journal Article
United States
JAMA Ophthalmol. 2024 May 30:e241712. doi: 10.1001/jamaophthalmol.2024.1712.
PY - 2024
SN - 2168-6165 (Print)
2168-6165
T2 - JAMA Ophthalmol
TI - Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment
ER -